EE+ POEM Archive
Normotensive patients at intermediate risk of CV disease do not benefit from ARB + HCTZ (HOPE-3)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Normotensive Patients at Intermediate Risk of CV Disease Do Not Benefit From ARB + HCTZ (HOPE-3)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314047/all/Normotensive_patients_at_intermediate_risk_of_CV_disease_do_not_benefit_from_ARB_+_HCTZ__HOPE_3_.
Normotensive patients at intermediate risk of CV disease do not benefit from ARB + HCTZ (HOPE-3). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314047/all/Normotensive_patients_at_intermediate_risk_of_CV_disease_do_not_benefit_from_ARB_+_HCTZ__HOPE_3_. Accessed April 19, 2024.
Normotensive patients at intermediate risk of CV disease do not benefit from ARB + HCTZ (HOPE-3). (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314047/all/Normotensive_patients_at_intermediate_risk_of_CV_disease_do_not_benefit_from_ARB_+_HCTZ__HOPE_3_
Normotensive Patients at Intermediate Risk of CV Disease Do Not Benefit From ARB + HCTZ (HOPE-3) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314047/all/Normotensive_patients_at_intermediate_risk_of_CV_disease_do_not_benefit_from_ARB_+_HCTZ__HOPE_3_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Normotensive patients at intermediate risk of CV disease do not benefit from ARB + HCTZ (HOPE-3)
ID - 1314047
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314047/all/Normotensive_patients_at_intermediate_risk_of_CV_disease_do_not_benefit_from_ARB_+_HCTZ__HOPE_3_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
